Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.100
+0.145 (15.12%)
At close: Jul 6, 2026, 4:00 PM EDT
1.130
+0.030 (2.73%)
Pre-market: Jul 7, 2026, 5:43 AM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $4.06 million as of July 7, 2026. Its market cap has increased by 94.53% in one year.
Market Cap
4.06M
Enterprise Value
634.49K
1-Year Change
94.53%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $624.51M to $4.06M, a decrease of -99.35%. That is a compound annual growth rate of -68.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 4.06M | 67.39% |
| Dec 31, 2025 | 2.43M | -53.56% |
| Dec 31, 2024 | 5.22M | 43.70% |
| Dec 29, 2023 | 3.64M | -78.64% |
| Dec 30, 2022 | 17.02M | -97.28% |
| Feb 18, 2022 | 624.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 4.22M |
| Ensysce Biosciences | 4.17M |
| GeoVax Labs | 4.13M |
| Matinas BioPharma Holdings | 4.06M |
| Propanc Biopharma | 4.03M |
| Decoy Therapeutics | 3.89M |
| Artelo Biosciences | 3.87M |
| Galmed Pharmaceuticals | 3.75M |